Year: 2024

Northern Horizon Capital AS, the management company of Baltic Horizon Fund, hereby informs that Jūratė Gaspariūnienė was elected as a member of the management board of  Northern Horizon Capital AS with a term starting on 1 December 2024. The appointment of a new management board member is related to Edvinas Karbauskas’s resignation from the board, which was announced to the market on 30 April 2024. Jūratė Gaspariūnienė joined Northern Horizon Group in January 2021 and she was in charge of entire retail portfolio in the Baltics. In 2024 she was promoted to the Head of Asset Management in the Baltics and Portfolio Asset Manager of the Baltic Horizon Fund. Before that, Jūratė worked in the commercial real estate sector as a Chief Operating Officer at MC GRUPĖ, a Commercial Real Estate Asset Property Manager, Head of Retail Operations...

DUBLIN and SHANGHAI, Nov. 21, 2024 (GLOBE NEWSWIRE) — PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD), today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 HighlightsTotal revenues in the quarter were RMB99,354.4 million (US$1 14,157.9 million), an increase of 44% from RMB68,840.4 million in the same quarter of 2023.Operating profit in the quarter was RMB24,292.5 million (US$3,461.6 million), an increase of 46% from RMB16,656.0 million in the same quarter of 2023. Non-GAAP2 operating profit in the quarter was RMB26,770.5 million (US$3,814.8 million), an increase of 48% from RMB18,125.8 million in the same quarter of 2023.Net income attributable to ordinary shareholders in the quarter was RMB24,980.7 million (US$3,559.7 million), an increase...

Event to be held December 18-21, 2024, at The Star, the Dallas Cowboys Practice Facility in Frisco, TX SCOTTSDALE, Arizona, Nov. 21, 2024 (GLOBE NEWSWIRE) — Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform to aid high school athletes in the recruitment process, provides an update on the upcoming 3rd Annual US Army Bowl National Combine, powered by Signing Day Sports, set to take place from December 18-21, 2024, at The Star, the state-of-the-art Dallas Cowboys Practice Facility in Frisco, Texas. The US Army Bowl National Combine sets the stage for the prestigious US Army National High School All-Star Game, a premier event showcasing the nation’s top student-athletes. Throughout this NFL-style, three-day combine, prospects from nearly...

LAS VEGAS, Nov. 21, 2024 (GLOBE NEWSWIRE) — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced the hiring of Bryant Ison as VP of National Marketing. Bryant Ison joins Planet 13 with a long history of driving brand growth for iconic global brands, such as Pepsi, Band-Aid, and Clorox. Ison has deep experience in the cannabis industry launching new brands and he will spearhead all marketing activities to grow the Planet 13 business. “As part of our multi-year growth strategy, we are focused on significantly expanding the reach and sales of our award-winning in-house brands including our flower and extract brands Trendi and Medizin, HaHa gummies, and Dreamland chocolates,” said Bob Groesbeck, Co-CEO of Planet 13....

Frontline plc.’s preliminary third quarter 2024 results will be released on Wednesday November 27, 2024, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section at www.frontlineplc.cy ahead of the conference call. In order to attend the conference call you may do one of the following: a. WebcastGo to the Investor Relations section at www.frontlineplc.cy and follow the “Webcast” link, or access directly from the link below. Frontline plc Q3 2024 Webcast b. Conference CallParticipants will need to register online prior to the conference call via the link below. Dial-in details will be available when registered.              Frontline plc Q3 2024 Conference Call A Q&A session will be held after the teleconference/webcast....

PITTSBURGH, Nov. 21, 2024 (GLOBE NEWSWIRE) — Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on innovative therapies for serious diseases with significant unmet needs, today announced the completion of dosing for the first cohort in its multi-center Phase 2a clinical trial of LP-310, a liposomal-tacrolimus oral rinse being developed for the treatment of Oral Lichen Planus (OLP). In this first cohort, eight participants received a dose of 0.25 mg LP-310, with promising initial results. No product-related serious adverse events were reported. Pharmacokinetic data demonstrated that whole blood tacrolimus levels in all patients were either undetectable or minimal, highlighting LP-310’s potential to deliver localized therapeutic effects while minimizing systemic...